Obinutuzumab is used in the treatment of blood cancer, specifically chronic lymphocytic leukemia.
How Obinutuzumab works Obinutuzumab functions by identifying and binding to specific proteins, specifically CD20, found on leukemia cells as well as some healthy blood cells. It eliminates leukemia cells directly or with the assistance of the immune system.
Common side effects of Obinutuzumab include nasopharyngitis (inflammation of the throat and nasal passages), upper respiratory tract infection, rash, flu, dermatitis, bronchitis (inflammation of the airways), eczema, swelling of lymph nodes, and oropharyngeal pain.